Perrigo media headlines

By Perrigo Company ALLEGAN, Mich., May 24, 2012 -- /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo Chairman, President and Chief Executive Officer, Joseph C. Papa, will present at the Jefferies Global Healthcare ... Perrigo's top brass to make presentations on the East and West Coasts - Michigan Business Review - MLive.com

Zacks.com - May 23, 2012 Good news flowed in at Perrigo Company (PRGO - Analyst Report) when the US Food and Drug Administration (FDA) cleared its generic version of KV Pharmaceutical Company's vaginal cream Gynazole?1. Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream - MarketWatch (press release)

PR Newswire (press release) - May 22, 2012 ALLEGAN, Mich., May 22, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the US Food and Drug Administration for its abbreviated new drug application (ANDA) for butoconazole nitrate 2% ...

Reuters Key Development - May 22, 2012

Perrigo Announces FDA Final Approval and Launch of Store Brand OTC ... MarketWatch (press release) - May 18, 2012 ALLEGAN, Mich., May 18, 2012 /PRNewswire via COMTEX/ -- Perrigo Company (NASDAQ:PRGO) today announced that it has received final approval from the US Food and Drug Administration for its abbreviated new drug application (ANDA) for Lansoprazole capsules ... Perrigo Receives FDA Approval For ANDA For Lansoprazole 15 Mg Capsules - NASDAQ

Investment analysts at Stifel Nicolaus began coverage on shares of Perrigo (NASDAQ: PRGO) in a note issued to investors on Tuesday.

Perrigo Company to Present at the Bank of America Merrill Lynch 2012 ... MarketWatch (press release) - 22 hours ago ALLEGAN, Mich., May 15, 2012 /PRNewswire via COMTEX/ -- Perrigo Company (NASDAQ:PRGO) today announced that Perrigo Executive Vice President and Chief Financial Officer, Judy L. Brown, will present at the Bank of America Merrill Lynch Healthcare ...

Wall St. Cheat Sheet - May 13, 2012 By Lindsey Grossman On Tuesday, Perrigo Company (NASDAQ:PRGO) reported its third quarter earnings and discussed the following topics in its earnings conference call.

Movie News Guide (blog) - May 10, 2012 Perrigo (NASDAQ: PRGO)'s stock had its ?buy? rating restated by equities researchers at Auriga in a report issued on Wednesday. Deutsche Bank Lowers Price Target on Perrigo (PRGO) - Junction Report

Daily Political - May 10, 2012 Perrigo (NASDAQ: PRGO)'s stock had its ?hold? rating reiterated by equities research analysts at Needham & Company in a research note issued to investors on Wednesday. Perrigo shares fall as Q3 revenue falls short of analysts' forecasts - Proactive Investors USA & Canada UPDATE: Deutsche Bank Lowers Perrigo's PT - Benzinga

Perrigo (NASDAQ: PRGO)'s stock had its ?neutral? rating restated by Zacks in a report issued on Wednesday. They currently have a $105.00 target price on the stock.

By Christine Harvey on May 09, 2012 Israel's efforts to simplify corporate structures and cut cross ownership will force companies to sell assets, creating opportunities for private equity funds, said Markstone Capital Group's Ron Lubash. Tue: Perrigo pushes market down - Globes Israel Stocks: Allot Communications, Babylon, EZchip and Perrigo - Bloomberg

Deutsche Bank (NYSE: DB) lowered their price target on shares of Perrigo (NASDAQ: PRGO) from $103.00 to $101.00 in a research note issued on Wednesday. UPDATE: Deutsche Bank Lowers Perrigo's PT - Benzinga

Needham & Company Maintains a 'Hold' on Perrigo Co. (PRGO); Disappoints on Top ... StreetInsider.com (subscription) - 6 hours ago Analyst, Elliot Wilbur, said, "PRGO has put an end to a 3.5-year string of strong beat-and-raise Qs with disappointing 3QF12 results.

By Christine Harvey on May 08, 2012 Perrigo Co. (PRGO) slumped the most in six months in New York trading after the largest US maker of generic over-the-counter drugs reported revenue (PRGO) that missed analysts' estimates.